Acne Drugs Market
Acne drugs are medications used to treat a dermatological infection caused by the inflammation in the hair follicles on the skin. It is generally due to hormonal imbalance, oily skin, accumulation of dead skin cells, bacteria, stress, inadequate water intake, and excessive consumption of sugars, salts, or carbohydrates. Few acne drugs are topical medications, such as retinoids, salicylic and azelaic acid-based ointments, and dapsone-based gels, coupled with antibiotics, anti-androgen agents, and isotretinoin. These drugs reduce oil production in the body, accelerate skin cell turnover, reduce acne breakouts, scarring, damage the skin, and prevent inflammation.
Request for a free sample copy of this report: https://www.imarcgroup.com/acne-drugs-market/requestsample
The growing incidences of skin-related diseases, such as acne vulgaris, are driving the acne drug market. Moreover, increasing awareness towards the benefits of using premium skin care products and the emergence of effective therapeutics and treatments with lower side effects are augmenting the market growth. Additionally, the growing traction for products containing natural ingredients has compelled the manufacturers to develop products infused with natural herbs and organic ingredients to treat acne. Furthermore, elevating consumer disposable income levels and the growing popularity of customized acne drugs as per the user’s skin type, are expected to propel the acne drugs market.
Acne Drugs Market 2020-2025 Analysis and Segmentation:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
• Allergan Plc
• Bausch Health Companies Inc.
• Bayer Aktiengesellschaft
• Cipher Pharmaceuticals Inc.
• Galderma Holding SA
• Johnson & Johnson
• Pfizer Inc.
• Reckitt Benckiser Group Plc
• Skinvisible Pharmaceuticals Inc.
• Sun Pharmaceutical Industries Limited
• Teva Pharmaceutical Industries Ltd
The report has segmented the market on the basis of acne type, drug class, drug type, route of administration and region.
Breakup by Acne Type:
Breakup by Drug Class:
• Hormonal Agents
• Combination Drugs
Breakup by Drug Type:
• OTC Drugs
• Prescription Drugs
Breakup by Route of Administration:
Breakup by Region:
• North America
• Asia Pacific
• Latin America
• Middle East and Africa
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Follow us on twitter: @imarcglobal
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Acne Drugs Market here
News-ID: 2155744 • Views: 250
More Releases from IMARC Group
Hyperlipidemia Drugs Market Share, Size, Growth, Opportunities, Industry Analysi …
According to the latest report by IMARC Group, titled, “Hyperlipidemia Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025", the global hyperlipidemia drugs market grew at a CAGR of around 3% during 2014-2019. Hyperlipidemia refers to a health condition where an excessive quantity of lipids, such as cholesterol and triglycerides, is produced into the blood. This condition may lead to cardiac stroke, peripheral vascular disorders, atherosclerosis, diabetes, obesity,
Modular Instruments Market Research 2020-2025: Profitable Customized Report
According to the latest report by IMARC Group, titled “Modular Instruments Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025,” the global modular instruments market size reached US$ 1.4 Billion in 2019. Modular instruments are devices used for configuring automated test and measurement (T&M) equipment, which assist in the designing, developing, maintaining, verifying and repairing of different electronic and mechanical products. These instruments have a frame in which
China Pollution Mask Market Research 2020-2025: Profitable Customized Report
According to the latest report by IMARC Group, titled “China pollution mask Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025”, the pollution mask market in china grew at a CAGR of 10% during 2014-2019. Pollution masks are used as a protective face covering for filtering out air pollutants. These masks are essentially required to prevent chronic respiratory conditions, such as asthma, lung infection, COPD, etc. Pollution masks are
Asia Pacific Biometrics Market Research 2020-2025: Profitable Customized Report
According to the latest report by IMARC Group, titled “Asia Pacific Biometrics Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025”, the Biometrics market size in Europe reached a strong growth in 2019. Biometrics refers to a security component that helps in authenticating the identity of individuals based on their physical or behavioral characteristics. It is commonly bifurcated into physiology- and behavior-based biometrics. Physiological characteristics for biometrics majorly include
More Releases for Drug
Biologics Drug Discovery Market
2019-2025 Biologics Drug Discovery Market Report with Depth Analysis The biologics drug discovery involves target identification, hit-to-lead stage, lead identification and optimization. The report presents a comprehensive overview, market size, shares, and growth opportunities of Biologics Drug Discovery market by product type, application, key manufacturers and key regions. Request For Free report Sample -https://www.reportsmonitor.com/request_sample/306320 Scope of the Report: Furthermore, Biologics Drug Discovery Market report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers or
Opioid Antagonist Drug Market
The global market has been prognosticated to earn demand from popular types of products such as external use, oral and applications such as household and hospital. The Company has made available another publication in its Healthcare archive of market intelligence reports, which is titled “Global Opioid Antagonist Drug Market Research Report 2018.” While the threat of substitutes and technological risks could have an unfavorable impact on the global market, potential
Drug and cosmetics
Drug and Cosmetics Conferences regards each one of the individuals to go to the On “Drug and Cosmetics” amidst October 17-October 18, 2018 in Toronto, Canada which melds brief keynote presentations, speaker talks, Exhibition, Symposia, Workshops. Drug and Cosmetics Congress is one of the meetings and conferences which will be visited by all the prestigious cosmetologists, Scientists, fiery inspectors, postgraduates, affiliations, business meanders under a solitary rooftop. DRug and cosmetics BLESSY MATHEW Program
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: firstname.lastname@example.org or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: email@example.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning